Improving The Digital Landscape At Quell Therapeutics

ProPharma has been instrumental in the digital transformation of Quell Therapeutics, a growing UK-based cell therapy company. Quell leverages engineered TReg cell therapies to treat autoimmune and inflammatory diseases and is rapidly expanding its R&D function through multiple academic partnerships and an expanding in-house pipeline. While Quell currently outsources manufacturing for its early-phase clinical trial products, it aims to support in-house clinical supplies in the future.

Beginning with our Digital Blueprint assessment and conducting a series of stakeholder interviews, ProPharma identified and prioritized key areas to enhance data integrity and compliance, improve data management and traceability, and facilitate data sharing and collaboration.

Find out what happened next by downloading the case study below.